Endovascular thrombectomy for pediatric stroke due to M2 occlusion is linked to greater functional or neurologic outcomes ...

University of Calgary researchers published findings from Canada's largest ever acute stroke clinical trial in 2022. It ...

Hoffmann-La Roche Limited (Roche Canada) is proud to announce that Health Canada has granted market authorization for TNKase® ...

Health Canada recently approved the injection treatment for acute ischemic stroke in adults, the first stroke medicine ...

Precision medicine in the acute care of stroke has undergone significant advancements, particularly since 2015, when five ...

With well-defined targets and clear mechanism of action, Y-3 for Injection is able to exert multiple therapeutic effects. As the world’s first brain cytoprotectant developed based on the important ...

Longer PTR times during thrombectomy significantly increase the likelihood of death or hospice discharge and raise acute stroke care costs.

BASEL, Switzerland—Multiple randomized trials presented last week at the European Stroke Organisation Conference (ESOC) 2024 have bolstered the case that tenecteplase (TNK) is an effective—if not ...

Brain imaging provides an objective basis for the clinical inferences that direct individual patient management in the acute stroke setting. A brain CT or MRI scan is required for all patients with ...

Rapid Medical (TM), a leading developer of active endovascular devices, announces the completion of patient enrollment in the DISTALS Trial, a multicenter randomized study assessing the TIGERTRIEVER ...

Under current guidelines, intravenous thrombolysis is used to treat acute stroke only if it can be ascertained that the time since the onset of symptoms was less than 4.5 hours. We sought to determine ...